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Introduction 
The insulin mimetic properties of vanadium complexes are 
known for over a hundred years (since 1899) [1, 2]. It was also 
shown, that in patients suffering from diabetes type 2, lower lev-
el of vanadium in body than normal was found [3]. Moreover, up 
to now, there are no data suggesting, that there is any toxic effect 
for human both in short, and long term excluding gastrointes-
tinal discomfort [4,5]. Vanadium is a bio element and is uses 
as a diet supplement, for example to enhance weight training 
in athletes in doses much higher than recommended [6]. In the 
beginning of XXI century, it was suggested however that the 
vanadium administration is unnecessary [7,8]. In spite of these 
publications the investigations on vanadium continued, and en-
tered for phases I and II of clinical treatment [8,9]. In last decade 
the increase of interest in vanadium starts again [10]. The most 
study on vanadium insulin mimetic properties comes from in 
vitro studies, in 2017 a review in this subject appeared [11]. Still 
in study on its influence on humans the simplest V(IV) salts as 
vanadyl sulphate or vanadate’s were used [10]. 
The main problem with simple inorganic vanadium salts is 
their bioavailability. In 1990s first complex of vanadium(IV) 
with maltolato ligand (BMOV) was synthesized [12]. Today 
BMOV is used as a standard to access vanadium complexes 
effectiveness in a Type II diabetes. Still for bidentate organic 
ligands, as in BMOV, the mechanism shows that unliganded va-
nadium is the active component [13]. The investigation of more 
sophisticated vanadium complexes with polydentate ligands, 
and also with biologically active ligands, is now undertaken, in 
most cases Schiff base ligands are used [14-16]. The inorganic 
ligands show better bioavailability of vanadium and show much 
higher stability towards ligand dissociation, giving a new insight 
into our knowledge on a role of vanadium in biological systems.
In present paper we describe synthesis of three new vanadium 
complexes with tridentate ONO Schiff base ligands. The aim 
of this work was to investigate the stability of these complexes 
both in solution and in solid state, as a crucial information for 
practical applications in in vitro and in vivo studies. Three oxi-
dation states of vanadium were investigated: +3, +4 and +5. The 
correlation between oxidation state metal center and stability is 
discussed. 
Materials and Methods 
[V(acac)3], [VO(acac)2], 1,10-phenanthroline (phen), 5-hydrox-
ysalicylaldehyde, 3,5-dichlorosalicylaldehyde, phenylacetic 
hydrazide and 4-hydroxybenzhydrazide were of analytical 
grade (Aldrich) and were used as supplied in synthesis of com-
plexes 1-3. The complexes [V(L3)(HL3)]·EtOH (4), [VO(L4)
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benzohydrazide respectively) were synthesized as described 
elsewhere [17]. Ethanol (98%) of pharmaceutical grade was 
from Polmos and used as supplied. All other solvents were of 
analytical grade and were used as supplied. Microanalysis of 
carbon, hydrogen and nitrogen were performed using Elementar 
Vario MICRO Cube elemental analyzer. The magnetic suscep-
tibility measurements were performed on a SHERWOOD SCI-
ENTIFIC magnetic susceptibility balance. Thermogavimetric 
measurements were performed on a TGA/SDTA 851e Mettler 
Toledo Microthermogavimeter in air or under argon atmosphere 
with scan speed 10 oC/min. The electronic absorption spectra 
were recorded on Shimadzu UV-3600 UV-VIS-NIR spectro-
photometer equipped with a CPS-240 temperature controller. 
Complex stability measurements in DMSO/H2O (20 µL/3mL) 
mixture were performed at a native pH (7.00) and at pH = 2.00 
(0.1M KCl, HCl added to adjust the pH). The spectra were meas-
ured every 340 s at 37.0 oC on Shimadzu UV-3600 UV-Vis-NIR 
spectrophotometer in 1 cm UV cuvettes. 
Synthesis 
The reaction was carried in one step. The Schiff base ligands 
H2L1 and H2L2 were synthesized in situ in reaction between al-
dehydes (5-hydroxysalicylaldehyde for H2L1 and 3,5-dichlorosa-
licylaldehyde for H2L2) and hydrazides (phenylacetic hydrazide 
for L1 and 4-hydroxybenzhydrazide for H2L2) in 1 : 1 molar ratio 
and after completing of the reaction [V(acac)3] (for 1 and 4) or 
[VO(acac)2] (for 2, 3 and 5 complexes) or VOSO4aq (for 6) was 
added. The reaction proceeds under anaerobic conditions (Ar) 
due to fast oxidation of V(IV) to V(V) in condition used as can 
be seen comparing synthesis of 1 and 3. 
The addition of phen as a co-ligand (for 2) results in fast pre-
cipitation of the complex by filling the coordination sphere of 
vanadium and in stabilization of V(IV) oxidation state. The 
products are stable in air, soluble in organic solvents and almost 
insoluble in water. 
[V(L1)(HL1)], 1
5-hydroxysalicylaldehyde (0.278 g, 2.0 mmol), phenylacetic hy-
drazide (0.301 g, 2.0 mmol) and EtOH (21 ml) were refluxed 
under Ar for 13 minutes with formation of yellow transparent 
solution. Then [V(acac)3] (0.349 g, 1.0 mmol) was added and 
the reflux was continued for 28 minutes. The solution imme-
diately turns brown. In two minutes after addition of [V(acac)3] 
the brown product starts to precipitate. Then it was filtered off, 
washed with EtOH and dried in air. Yield 0.2665 mg . MW = 
589.49. Anal. Calcd. for C30H26N4O6V: C, 61.12; H, 4.45; N, 9.50 
%. Found: C, 60.52; H, 4.18; N, 9.47 %.  FT-IR (KBr, cm-1): 3026 
(w), 2355 (w), 1571 (w), 1554 (s), 1518 (s), 1480 (w), 1432 (m), 
1438 (m), 1392 (w), 1364 (w), 1329 (w), 1276 (w), 1245 (w), 1227 
(m), 1173 (s), 1116 (w), 1006 (w), 951 (w), 827 (s), 791 (w), 726 
(m), 694 (w), 652 (w), 566 (w), 519 (w), 490 (w), 450 (w), 427 (w). 
Complex is paramagnetic, µ =  2.38 µB. 
[VO(L2)(phen)]·H2O, 2
3,5-dichlorosalicylaldehyde (0.287 g, 1.5 mmol), 4-hydroxyben-
zhydrazide (0.226 g, 1.5 mmol) and EtOH (50 ml) were refluxed 
under Ar for 10 minutes. The light yellow transparent solution 
was formed and then solid [VO(acac)2] (0.393 g, 1.5 mmol) was 
added (the mixture turns to dark brown) and the mixture was re-
fluxed for additional 20 minutes. Then phen (0.272 g, 1.5 mmol 
in 10 ml of EtOH) was added and the mixture was heated for 
additional 8 minutes. Next day the formed crystals were filtered 
off, washed with small amount of cold EtOH and dried in air. 
Yield 0.649 g. MW = 588.29. Anal. Calcd. for C26H18Cl2N4O5V: 
C, 53.08; H, 3.08; N, 9.52 %. Found: C, 52.89; H, 3.15; N, 9.33 %. 
FT-IR (KBr, cm-1): 3436 (m), 1607 (vs), 1520 (w), 1497 (vs), 1436 
(w), 1423 (vs), 1375 (m), 1352 (m), 1301 (w), 1274 (w), 1211 (m), 
1183 (m), 1166 (m), 1141 (w), 1101 (w), 1034 (w), 954 (s), 907 (w), 
848 (m), 760 (m), 724 (m), 644 (w), 618 (w), 562 (w), 511 (w), 448 
(w), 431 (w). Complex is paramagnetic, µ =  1.32 µB.
[VO2(L1)]·H2O, 3
5-hydroxysalicylaldehyde (0.208 g, 1.5 mmol) and phenylacetic 
hydrazide (0.227 g, 1.5 mmol) in 50 ml of EtOH were refluxed 
for 15 minutes under Ar yielding a transparent light yellow solu-
tion. Then [VO(acac)2] (0.399 g, 1.5 mmol) was added and the 
mixture was refluxed for 40 minutes giving yellow-black trans-
parent solution. Then it was evaporated in part (in air) yielding a 
dark-green oil liquid. After three days black muddy-like product 
was filtered off, washed with EtOH and dried in air. Yield 0.200 
g. MW = 370.23. Anal. Calcd. for C15H15N2O6V: C, 48.66; H, 
4.08; N, 7.57 %. Found: C, 48.14; H, 3.83; N, 6.31. FT-IR (KBr, 
cm-1): 3254 (w,br), 1657 (w), 1521 (s), 1445 (w), 1370 (w), 1351 
(w), 1281 (w), 1191 (w), 1119 (w), 1079 (w), 1033 (w), 977 (m), 
835 (w), 802 (w), 726 (w), 696 (w), 653 (w), 596 (w). Complex is 
diamagnetic.
Results and Discussion 
The reaction of tridentate ONO Schiff base and vanadium 
source in anaerobic conditions yield the formation of respec-
tive V(III) and V(IV) complexes. For this latter phen ligand was 
used as a co-ligand to fill the octahedral sphere. When phen was 
not added, the products were contaminated with by-products. 
When, after synthesis, reaction mixture was exposed to air, rap-
id oxidation to V(V) was observed with precipitation of 3. For 
synthesized complexes 1-3 their formula was proposed basing 
on analytical data, IR spectra and magnetic moment measure-
ments. The magnetic moment shows, that complex 1 contains 
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mainly V(III), but is slightly contaminated with V(IV) - all pre-
sented here data are for freshly prepared complex. After 8 years 
(in period 2010-2018) of keeping 1 in a solid state in air, the 
magnetic susceptibility was found to be equal to 1.63 µB indi-
cating oxidation of V(III) to V(IV), but the IR spectrum remains 
almost unaltered, indicating no presence of intense bands which 
could be attributed to V=O group. All this shows that oxidation 
does not change the nonoxido character of the complex. Com-
plexes 2 and 3 were found to be stable in a solid state. 
Thermal stability measurements
The thermogravimetric analysis of complexes 1-6 was per-
formed in ca 25-1000 oC at scan speed 10 oC. The SDTA spectra 
were measured in the same temperature range. For two com-
plexes (3 and 6) the measurements were repeated under anaer-
obic conditions (Ar). The obtained results are presented sepa-
rately for V(III), V(IV) and V(V) complexes in Figs 1, 2 and 3 
respectively for measurements performed in air, while at Fig. 4 
results under Ar are presented.  
Figure 1. The TG (black, solid line) and SDTA (blue, dotted line) curves for complexes 1 (left) and 4 (right) in air, scan speed 10oC/min.
Figure 2. The TG (black, solid line) and SDTA (blue, dotted line) curves for complexes 5 (left) and 2 (right) in air, scan speed 10oC/min.
Figure 3. The TG (black, solid line) and SDTA (blue, dotted line) curves for complexes 3 (left) and 6 (right) in air, scan speed 10oC/min.
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The numerical data of TG and SDTA measurements are col-
lected in Table 1. The Tmax denote the SDTA maximum or mini-
mum, the type of process is given (exothermal or endothermal). 
The mass of the sample at every step of decomposition were 
calculated when SDTA curve reaches the background level, thus 
at the plateau or shoulder on TG curve. 

















































































































a  The SDTA Tmax was not listed due to the problems with Tmax determina-
tion, as shown in Fig. 4. 
Presented TG and SDTA curves indicate that the decompo-
sition processes are very complicated. The solvent release is 
probably possible after structure damage, thus decomposition 
temperature overlaps with ligand L decomposition. Similar sit-
uation is for coordinated EtOH molecules. The presented TG 
curves show, that ligand L is decomposed in two steps, in the 
first one hydrazide part is released, in second, overlapped with 
the first one, salicylaldehyde part is decomposed. As all process-
es overlaps it is difficult to assign the observed mass loose with 
calculated one. For complexes with phen ligand, it is released 
first, and then ligand L is decomposed. For example for complex 
2, calculated for phen and H2O release Δmcalc = 33.7%, while 
observed 34.1%, total mass loose calculated for phen, H2L2 and 
2H2O release Δmcalc = 88.6%, observed Δm = 87.1. For com-
plex 5,  for phen and H2O release Δmcalc = 34.6 %, observed Δm = 
35.7%, for H2L4, phen and H2O release Δmcalc = 88.8%, observed 
Δm = 87.7 %. In most cases decompositions are the endothermic 
processes, the only exclusions are complexes of V(III) (1 and 
4) where exothermic processes dominate. This is probably con-
nected with the oxidation energy of V(III) to finally V(V). The 
decompositions under Ar are much more complicated, as shown 
in Fig. 4. At the beginning of the process, TG curves in air and 
under Ar are relatively similar, but later processes complicates, 
and even at 1000 oC plateau is not reached on TG curve. This is 
probably connected with formation of carbides of vanadium in 
anaerobic conditions. 
The most important is the comparison of complex thermal 
stability. The V(V) complexes (3 and 6) decomposition pro-
cesses start almost at room temperature as shown in Fig. 3. It 
Figure 4. The TG (black, solid line) and SDTA (blue, dotted line) curves for complexes 3 (left) and 6 (right) under Ar, scan speed 10oC/min.
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indicates, that solvent molecule (EtOH) is weakly coordinat-
ed to the vanadium center and, after it release at crystal faces, 
the structure starts to collapse and constant decrease of mass, 
without defined plateau on TG curve, is observed. The most sta-
ble seems the V(IV) complexes, with decomposition processes 
starting over 250 oC (for 2 only water of hydration is released). 
For V(III) complexes (1 and 4) complexes are thermally stable 
up to ca. 200 oC. Similar results were obtained also for other 
vanadium complexes of that type of ligands. For example for 
[VO(L)(EtO)(EtOH)] (where H2L = Schiff base ligand derived 
from 5-methoxysalicylaldehyde and phenylacetic hydrazide) 
[18] the V(V) complex is stable up to ca 50 oC, then solvent mole-
cules are released but still after this process the complex is stable 
up to 133 oC.  
Spectroscopic measurements
The stability of the solutions of the complexes were studied in 
DMSO-H2O (20µL + 3mL) mixture. This volume ratio was the 
same, as in later biological studies both in vivo and in vitro. 
As all investigated complexes were almost insoluble in water, 
DMSO was used as it had the best solubility of the complexes 
studied and is biologically neutral. To lower the DMSO con-
tent and to prevent complex precipitation, the mixtures of DM-
SO-H2O were used. The stability was studied by measuring the 
UV-Vis spectra versus time at T = 37 oC to mimic behavior in 
human body. As vanadium complexes were later used in biolog-
ical studies and as pharmaceutics should be admitted orally, the 
complexes should be stable enough to pass through human di-
gestion system (the most challenging is the pH of the stomach). 
We decided to study the solution stability both at neutral pH (7.0) 
as reference (pH resembling the in vitro conditions), and at pH = 
2.0 (close to that of stomach; in range 1.5–2.5). The spectra were 
recorded every 340s and were measured in period of 2 hours 
(time much longer than required for passage through digestion 
system). The results are presented in Figs. 5-7. 
At the first look the spectra at pH = 2.0 seem to change slower 
than that at pH 7.0. But looking in detail, at Figs 5 - 7, it can 
be seen, that at pH = 2.0 the band above 400 nm, attributed to 
coordinated ligand L, is or not present (Figs 5, 7) or its intensity 
is very low (Fig. 6). This indicates, that before the first spec-
trum measurement the complexes 1-3 decomposed. Still some 
remaining absorption in this range for complex 2 indicates, that 
this is the most stable complex at pH = 2.0. At pH = 7.0 both 
complexes 1 and 2 are relatively stable, while complex 3 is not. 
Figure 5. The electronic spectra of  1 in DMSO-H2O mixture (20µl + 3 ml) at pH = 7.00 (left) and 2.00 (right). T = 37oC, d = 1cm, c 
= mol/dm3, 15 spectra measured every 340s. The arrows indicate the direction of the changes
Figure 6. The electronic spectra of  2 in DMSO-H2O mixture (20µl + 3 ml) at pH = 7.00 (left) and 2.00 (right). T = 37oC, d = 1cm, c 
= mol/dm3, 15 spectra measured every 340s. The arrows indicate the direction of the changes
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Conclusions 
The thermal stability of vanadium at different oxidation state 
was described and compared, both for solid state and in solution. 
It was found, that V(IV) complexes are the most stable in all 
conditions studied. The V(III) complexes are relatively stable in 
a solid state and in solution at pH 7.0 but slow process of V(III) 
oxidation to V(IV) (observed in 8 year period), with preserving 
the nonoxido character of vanadium center, exclude them for fu-
ture applications as metalopharmaceutics. The V(V) complexes, 
possessing solvent molecules as ligands, are the least stable both 
in solution and in a solid state. In a solid state this is probably 
connected with solvent release on the crystal border, resulting 
in structure collapse and stepwise decomposition of whole crys-
tals. In solution, it seems that 2 is the most stable among V(V) 
complexes and at least part of the complex can pass through 
stomach without decomposition. In conclusion we suggest, that 
V(IV) complexes are most suitable for applications in biological 
systems. 
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